Core Viewpoint - The trade tensions between the United States and Canada are easing, with Canada announcing the cancellation of several retaliatory tariffs on U.S. goods in response to the U.S. lowering tariffs on Canadian products [1][2]. Group 1: Canada-U.S. Trade Relations - Canadian Prime Minister Carney announced the cancellation of multiple retaliatory tariffs on U.S. goods, effective September 1, while maintaining tariffs on U.S. automobiles, steel, and aluminum temporarily [2][3]. - Carney emphasized that the measures are a response to the U.S. lowering tariffs on Canadian goods and highlighted the restoration of free trade for the majority of goods between the two countries [3][4]. - The average tariff rate imposed by the U.S. on Canadian goods is approximately 5.6%, which is relatively low compared to other trading partners [3][4]. Group 2: U.S. Tariff Investigations - President Trump announced a significant tariff investigation on imported furniture, stating that the investigation will be completed within 50 days, with unspecified tariffs to be applied to furniture from other countries [6][7]. - This investigation aims to revitalize the U.S. domestic furniture manufacturing industry, which has seen price increases due to previous tariff hikes on major furniture importing countries, including Vietnam [7][8]. - The consumer price index (CPI) for furniture and bedding has shown significant price increases, with June and July seeing rises of 0.4% and 0.9%, respectively, following a period of deflation [7].

Core Viewpoint - The speech by Federal Reserve Chairman Jerome Powell has significantly influenced the gold market, leading to a notable price increase following his remarks on potential interest rate adjustments [1]. Group 1: Market Reaction - Gold experienced a rebound after hitting a low of $3321, surging to $3378 post-Powell's speech, and closing at $3371, forming a strong bullish candlestick [1]. - The market is closely monitoring Powell's comments for further insights, as any new perspectives on the Federal Reserve's policy could impact market sentiment on Monday [1]. Group 2: Future Outlook - If the market interprets Powell's remarks as dovish or if significant risk events occur over the weekend, gold prices could break above $3380, with targets set around $3400 [2]. - Conversely, if Powell's comments are seen as hawkish or geopolitical risks diminish, a drop below $3360 could lead to short positions, targeting $3340-$3330 [2]. - The gold market is currently at a critical technical juncture, and the upcoming week may set the tone for the fourth-quarter trends [2].

Group 1 - The U.S. government is initiating a significant tariff investigation on furniture imports, which is expected to conclude within 50 days [1] - The investigation will result in an unspecified tariff rate on furniture entering the U.S. from other countries [1] - This move aims to bring furniture manufacturing back to states like North Carolina, South Carolina, and Michigan, as well as other states in the union [1]

Group 1 - The core issue in the US-EU trade negotiations is significant disagreement over pharmaceutical tariffs, which has become a major obstacle [1] - The new trade agreement includes a 15% tariff on EU products entering the US and a commitment from the EU to invest an additional $600 billion and purchase $750 billion worth of US energy [1] - There is a preliminary consensus on the 15% tariff for EU pharmaceutical exports, but the US plans to initiate a Section 232 investigation into the pharmaceutical sector in the coming weeks [1][3] Group 2 - The agreement framework lacks specific details, making it appear overly simplistic compared to typical trade agreements that require years of negotiation and extensive documentation [2] - The focus will now shift to the risks associated with the interpretation and implementation of the agreement, which involves a mix of political and technical issues [3] - The US has begun investigations to assess whether imports in sectors like aerospace and semiconductors pose a national security threat, which could lead to additional tariffs [3]

Core Insights - GSK reported first-quarter sales of $9.46 billion, a 2% increase year-over-year and a 4% increase on a constant currency basis, surpassing analyst estimates of $7.46 billion [1] Vaccine Sales - Vaccine sales decreased by 8% to £2.09 billion, primarily due to lower demand for Arexvy and Shingrix [2] - Arexvy sales fell 57% to £78 million, while meningitis vaccine sales increased by 17% to £350 million [2] - Shingrix sales reached £867 million, down 8% [3] Specialty and General Medicines - Specialty Medicines sales grew by 16% to £2.93 billion, driven by strong performances in HIV, Respiratory, Immunology, Inflammation, and oncology [4] - General Medicines sales declined by 3% to £2.49 billion [4] Earnings and Future Plans - GSK reported a core EPS of $1.13, exceeding the consensus estimate of $1.04 [5] - The company plans to market five new specialty medicines this year, including the reintroduction of Blenrep for multiple myeloma [5] Guidance and Market Position - GSK reaffirms its 2025 guidance, expecting sales growth of 3% to 5% and core earnings per share growth of 6% to 8% [6] - Specialty Medicine sales are projected to increase by a low double-digit percentage, while vaccine revenue is expected to decline by a low single-digit percentage [7] Stock Performance - GSK stock rose by 3.57% to $40.37 during the premarket session [7]

Market Overview - The Hong Kong stock market rebounded, with the Hang Seng Index rising by 0.6% to close at 23,483.32 points, with a total trading volume of 199.765 billion HKD [1] - The Hang Seng Tech Index increased by 1.01%, while the Hang Seng China Enterprises Index rose by 0.44% [1] - Market sentiment has been optimistic, but there are concerns about overseas risks as the U.S. tariff investigation results are expected soon [1] Blue-Chip Performance - Shenzhou International (02313) saw a strong performance post-earnings, rising by 12.66% to 62.3 HKD, contributing 9.75 points to the Hang Seng Index [2] - The company reported a revenue of 28.663 billion RMB for 2024, a year-on-year increase of 14.8%, and a net profit of 6.2406 billion RMB, up 36.9% [2] - Other notable blue-chip stocks include China Resources Mixc Lifestyle (01209) up 10.75%, Haidilao (06862) up 6.14%, and China Merchants Bank (03968) down 5.48% [2] Sector Highlights - The technology sector showed positive movement, with major stocks like Alibaba, Baidu, and Xiaomi rising over 1% [3] - Real estate and property management stocks experienced a broad increase, with China Resources Mixc Lifestyle rising over 10% [3] - The restaurant sector also saw gains, with Haidilao increasing by over 6% [3] Automotive Sector - The automotive sector showed signs of recovery, with companies like Leap Motor rising by 4.85% and Evergrande Auto experiencing a significant surge of 74.79% [3][8] - The Ministry of Commerce is promoting automotive consumption reforms, which may further stimulate the market [6] - The overall sentiment in the automotive market is expected to improve, with significant month-on-month growth anticipated in March [6] Earnings Reports - Haidilao reported a revenue of 42.755 billion RMB for 2024, a year-on-year increase of 3.14%, with a core operating profit of 6.23 billion RMB, up 18.74% [5] - The company served 415 million customers in 2024, a 4.5% increase from the previous year [5] - China Merchants Bank reported a slight decline in revenue for 2024, with total revenue of 337.488 billion RMB, down 0.48% year-on-year [7] Notable Stock Movements - Youjia Innovation (02431) surged by 31.79% after securing contracts with a well-known global car manufacturer [9] - Pop Mart (09992) reached a new high, with a revenue of 13.038 billion RMB for 2024, a 106.92% increase year-on-year [10] - COFCO Joycome (01610) rose by 8.51% after reporting a turnaround to profitability with a net profit of 538 million RMB [11]